Vancomycin Hydrochloride Injection 1.75 g per Vial, Single-Dose Powder Vials 50 mL (RX)

Discover one of the most trusted hospital-grade antibiotics for fighting life-threatening infections. Vancomycin Hydrochloride Injection is a powerful, broad-spectrum, prescription antibiotic medication designed for IV administration to treat severe bacterial infections. Manufactured by Mylan Pharmaceuticals, this formulation ensures purity, efficacy, and rapid delivery in critical medical settings.

Uses of Vancomycin Hydrochloride Injection

• Serious Gram-Positive Infections: Treats bloodstream infections, skin and soft tissue infections, bone and joint infections (osteomyelitis), meningitis, and severe respiratory infections (like pneumonia).
• MRSA & Resistant Infections: The drug of choice for infections caused by MRSA, Enterococcus faecalis, and other multi-drug-resistant pathogens.
• Clostridioides difficile-Associated Diarrhea (IV alternative): Vancomycin is used when oral therapy isn’t appropriate.
• Pre-Surgical Prophylaxis: Reduces the risk of infection during surgeries, especially in high-risk patients or when staph infection is a concern.

Key Benefits & Features

• Antibiotic Class: Glycopeptide / Antibacterial
• Strength: 1.75 g per Single-Dose Vial
• Volume: 50 mL (10 Vials/Box)
• Sterile Powder for Reconstitution
• Highest Purity & Potency
• Trusted by Hospitals & Clinics
• Convenient Single-Dose Packaging
• NDC: 72078-0065-99 | UPC: 372078065992

Applications & How to Use

Hospital & Clinical Settings:

• Preparation: Reconstitute the sterile powder with the appropriate diluent for IV administration.
• Administration: Infuse via intravenous drip over the prescribed duration, usually 60–90 minutes or as directed by a healthcare professional.
• Dosage: Should be determined by physician based on patient’s weight, age, renal function, and infection type.
• Monitoring: Regularly monitor vancomycin blood levels, kidney function, and patient’s response.

Safety Information & Side Effects

Common Side Effects:

• Red Man Syndrome (flushing, rash)
• Nephrotoxicity (kidney damage)
• Ototoxicity (hearing loss)
• Low blood pressure (hypotension)
• Injection site reactions (pain, irritation)

Serious Adverse Effects:

• Severe allergic reactions (anaphylaxis)
• Blood disorders (neutropenia, thrombocytopenia)
• Superinfection with long-term use

Important: Always use under direct medical supervision with appropriate dosing and blood level monitoring to minimize risks.

Related Top Antibiotic Products

• Ceftriaxone Injection (broad-spectrum IV/IM antibiotic)
• Piperacillin-Tazobactam Injection (for polymicrobial infections)
• Linezolid Injection (alternative for resistant Gram-positive infections)
• Daptomycin Injection (relapsed or refractory MRSA infections)
• Meropenem Injection (for extended-spectrum Gram-negative or unknown pathogens)

Why Choose Mylan Pharmaceuticals?

Mylan is an industry leader in producing FDA-approved, high-quality, sterile injectable antibiotics trusted worldwide by medical professionals, hospitals, and clinics.

Antibiotics, Infectious Disease Treatment, Hospital Medications, IV Antibiotic Therapy, MRSA Treatment, Severe Bacterial Infection, Glycopeptide Antibiotic, Hospital Supply, Injection Drug, Hospital-Grade Antibiotics, Vancomycin Uses, Medical Pharmacy Supplies, Antibiotic Injection, Sterile Injectable Antibiotics, Mylan Pharmaceuticals, Drug-Resistant Infection, Reconstitution Medication, Prescription (Rx) Antibiotics

Order Vancomycin Hydrochloride Injection 1.75 g now to ensure the highest standard of care for infectious diseases and critical antibiotic therapy.

Uses & Applications

Vancomycin Hydrochloride Injection is indicated for:

• Severe and life-threatening infections by susceptible gram-positive bacteria, especially:
  • MRSA (Methicillin-resistant Staphylococcus aureus) infections
  • MSSA (Methicillin-susceptible Staphylococcus aureus) in penicillin-allergic patients
  • Serious staphylococcal infections of skin, blood (sepsis), bone, or joints
  • Endocarditis (heart valve infection)
  • Lower respiratory tract infections (e.g., pneumonia)
  • Osteomyelitis (bone infection)
  • Meningitis (CNS infection)
  • Septicemia (bloodstream infection)
  • Enterococcal infections, in combination
• Alternative for patients allergic to penicillins/cephalosporins
• Clostridioides difficile colitis (oral vancomycin; this product is for IV use)

Benefits & Features

• Hospital-strength efficacy against MRSA and drug-resistant staph
• High-dose 1.75 g single-dose vial for flexible dosing and convenience in critical care
• Sterile, preservative-free powder for maximum patient safety
• Reliable, broad coverage for severe gram-positive pathogens
• Produced by Mylan Pharmaceuticals, a world leader in injectable antibiotics
• Quality assured packaging: 10 vials per box, each 50 mL for clinical efficiency
• Ideal for large hospitals, surgery centers, and emergency stockpiling
• Ease of reconstitution for IV infusion

Specifications

Instructions on How to Use

1. Reconstitution:
   • Add 30 mL of sterile water for injection to the vial.
   • Shake well until powder is fully dissolved.
   • Visually inspect for particulate matter or discoloration (solution should be clear).
2. Dilution:
   • Further dilute the reconstituted solution in a suitable IV fluid (e.g., 5% dextrose or 0.9% NaCl) as per provider instructions.
   • Final concentration should not exceed 5 mg/mL for intermittent infusion.
3. Administration:
   • Administer via slow IV infusion (typically over at least 60 minutes; longer for higher doses to reduce infusion reactions).
   • Do NOT administer as IV bolus (risk of severe adverse reaction).
4. Aseptic technique is mandatory.

Use only as directed by a licensed healthcare professional.

Dosage & Administration

• Adults: Dose individualized based on infection severity, renal function, and weight.
  • Usual adult dose: 15–20 mg/kg every 8–12 hours (max 2 g per dose in serious infections).
  • Adjust dose for renal impairment.
• Pediatrics: Dosing by weight and infection severity (consult specialist guidelines).
• Infusion Rate:
  • Infuse over at least 60 minutes (for doses ≤1 g) or 90–120 min (for higher doses).
• Therapeutic Drug Monitoring:
  • Serum vancomycin levels recommended for prolonged or high-dose use.
• Always individualize and adjust according to protocols and patient renal function.

Drug Interactions

• Other nephrotoxic drugs: Aminoglycosides, amphotericin B, cisplatin, etc.—increased risk of kidney damage
• Ototoxic agents: Loop diuretics (e.g., furosemide), aminoglycosides—may enhance hearing damage risk
• Anesthesia drugs: Rapid infusion with anesthetics may promote hypotension or rash
• Muscle relaxants: Potentiation possible

Always inform your provider of ALL current medications before starting vancomycin.

Side Effects & Warnings

Common Side Effects

• Pain, redness, or phlebitis at injection site
• Mild itching or rash (“Red Man Syndrome” if infused too rapidly)
• Mild nausea

Serious Adverse Reactions

• Nephrotoxicity (kidney damage): Increased risk with high doses, prolonged use, or combined nephrotoxins
• Ototoxicity (hearing loss): May be irreversible, especially in elderly or those with renal impairment
• Severe allergic/anaphylactic reactions: Wheezing, swelling, hypotension (rare but serious)
• Severe skin reactions: Stevens-Johnson syndrome (rare)
• Blood abnormalities: Neutropenia, thrombocytopenia (rare)
• “Red Man Syndrome”: Flushing, rash, low blood pressure due to rapid infusion—manage by slowing infusion rate

Warnings & Precautions

• Infuse over recommended time only. Rapid infusion can cause severe reactions.
• Periodic renal and hematologic monitoring in prolonged/high-dose course.
• Cautious use in patients with renal impairment, hearing impairment, or elderly.
• Not for IM or bolus injection use.
• Use only under direct health provider supervision.
• Discontinue immediately if severe reaction occurs.